This stock has never had its fda approval rerate. Its so cheap, especially to a big pharma who are always on the look out for new profit streams. A lot of posters going on that its needs to prove itself via sales? Why would a rival sit idle and let it steal their market share?
BOT - Anything but charting, page-9790
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 39.5¢ | $579.3K | 1.465M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 191279 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 507408 | 18 |
View Market Depth
| Last trade - 10.33am 02/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |